Hudson Bay Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.43M | Buy |
1,296,700
+146,300
| +13% | +$951K | 0.03% | 283 |
|
|
2025
Q1 | $9.12M | Buy |
1,150,400
+230,292
| +25% | +$1.83M | 0.03% | 256 |
|
|
2024
Q4 | $11.7M | Buy |
920,108
+200,000
| +28% | +$2.53M | 0.04% | 220 |
|
|
2024
Q3 | $10M | Buy |
720,108
+165,000
| +30% | +$2.3M | 0.04% | 196 |
|
|
2024
Q2 | $7.65M | Buy |
555,108
+445,108
| +405% | +$6.13M | 0.04% | 222 |
|
|
2024
Q1 | $1.82M | Buy |
110,000
+30,000
| +38% | +$496K | 0.01% | 396 |
|
|
2023
Q4 | $1.17M | Buy |
+80,000
| New | +$1.17M | 0.01% | 431 |
|